December 20, 2022 | Press Release National Study Confirms Effectiveness of New Tools for Standardizing Estrogen Receptor Testing News > Press Release > National Study Confirms Effectiveness of New Tools for Standardizing Estrogen Receptor Testing
December 1, 2025 Calibration Transforms Accuracy in HER2-Low Breast Cancer Testing International Study Published in Lancet: eBioMedicine BOSTON – November 19, 2025 — Boston Cell Standards today announced the publication of the CASI-01 study in Lancet: eBioMedicine... Continue Reading
December 20, 2022 Landmark Study by Boston Cell Standards Validates First Reference Standards for Immunohistochemistry Testing Continue Reading
December 19, 2022 FDA grants 510(k) clearance for Boston Cell Standards’ IHControls panel Continue Reading